Showing results (21-30 of 103) with videos related to
Sort By:
Pageof 11
Cancers|September 28, 2021
Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical PracticeSimona Bruzas, Sherko Kuemmel, Hakima Harrach, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 11, 2017
Serous Tubal Intraepithelial Carcinoma Associated With Extraovarian MetastasesStephanie Schneider, Sebastian Heikaus, Philipp Harter, et al.Current Oncology Reports|January 29, 2020
Low-grade Serous Tumors: Are We Making Progress?Nina Pauly, Sarah Ehmann, Enzo Ricciardi, et al.Annals of Surgical Oncology|July 14, 2016
Prognostic Impact of Port-Site Metastasis After Diagnostic Laparoscopy for Epithelial Ovarian CancerBeyhan Ataseven, Christoph Grimm, Philipp Harter, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2016
Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian CancerBeyhan Ataseven, Andreas du Bois, Philipp Harter, et al.Trials|July 6, 2019
Hypoglossal acupuncture for acute chemotherapy-induced dysgeusia in patients with breast cancer: study protocol of a randomized, sham-controlled trialHeidemarie Haller, Taige Wang, Romy Lauche, et al.The Oncologist|July 19, 2018
Adjuvant Subcutaneous Trastuzumab for HER2-Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III StudyKyung Hae Jung, Beyhan Ataseven, Mark Verrill, et al.Cancers|April 3, 2021
Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based ApproachesJanna Siemanowski, Birgid Schömig-Markiefka, Theresa Buhl, et al.Geburtshilfe Und Frauenheilkunde|June 17, 2024
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical CancerClemens Tempfer, Tanja Fehm, Dirk Vordermark, et al.European Journal of Cancer (Oxford, England : 1990)|November 3, 2009
Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer GroupWolfgang Eiermann, Erika Graf, Beyhan Ataseven, et al.Pageof 11